![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 9, 8101-8108, March 4, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





¶
From the
Center for Developmental Pharmacology and Toxicology, Children's Research Institute, Children's Hospital, Department of Pediatrics, The Ohio State University, Columbus, Ohio 43205 and the
Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53226
Mitogen-activated protein (MAP) kinases are critical mediators of innate immune responses. In response to lipopolysaccharide (LPS), MAP kinases are rapidly activated and play an important role in the production of proinflammatory cytokines. Although a number of MAP kinase phosphatases (MKPs) have been identified, their roles in the control of cytokine production have not been well defined. In the present report, we investigated the role of MKP-1 in alveolar macrophages stimulated with LPS. We found that LPS triggered transient activation of three MAP kinase subfamilies, ERK, JNK, and p38, in both immortalized and primary murine alveolar macrophages. MKP-1 was rapidly induced by LPS, and its induction correlated with the dephosphorylation of these MAP kinases. Blocking MKP-1 with triptolide prolonged the activities of both JNK and p38 in immortalized alveolar macrophages. Stimulation of primary alveolar macrophages isolated from MKP-1-deficient mice with LPS resulted in a prolonged p38 phosphorylation compared with wild type alveolar macrophages. Accordingly, these MKP-1-deficient alveolar macrophages also mounted a more robust and rapid tumor necrosis factor
production than their wild type counterparts. Adenovirus-mediated MKP-1 overexpression significantly attenuated tumor necrosis factor
production in immortalized alveolar macrophages. Finally, MKP-1 was induced by a group of corticosteroids frequently prescribed for the treatment of inflammatory lung diseases, and the anti-inflammatory potencies of these drugs closely correlated with their abilities to induce MKP-1. Our studies indicated that MKP-1 plays an important role in dampening the inflammatory responses of alveolar macrophages. We speculate that MKP-1 may represent a novel target for therapeutic intervention of inflammatory lung diseases.
Received for publication, October 15, 2004
* This work was supported by Grant R01AI57798 from NIAID of the National Institutes of Health (to Y. L.), Grant R01HL22563 from the NHLBI of the National Institutes of Health (to A. S.), and Training Grant T32HD043003 from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Center for Developmental Pharmacology and Toxicology, Children's Research Institute, Children's Hospital, Dept. of Pediatrics, The Ohio State University, 700 Children's Dr., Columbus, OH 43205. Tel.: 614-722-3073; Fax: 614-355-3455; E-mail: liuy{at}pediatrics.ohio-state.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P Bhavsar, M Hew, N Khorasani, A Torrego, P J Barnes, I Adcock, and K F Chung Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma Thorax, September 1, 2008; 63(9): 784 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kuwano, H. H. Kim, K. Abdelmohsen, R. Pullmann Jr., J. L. Martindale, X. Yang, and M. Gorospe MKP-1 mRNA Stabilization and Translational Control by RNA-Binding Proteins HuR and NF90 Mol. Cell. Biol., July 15, 2008; 28(14): 4562 - 4575. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cao, C. Bao, E. Padalko, and C. J. Lowenstein Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling J. Exp. Med., June 9, 2008; 205(6): 1491 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Calvert, L. G. Chicoine, Y. Liu, and L. D. Nelin Deficiency of mitogen-activated protein kinase phosphatase-1 results in iNOS-mediated hypotension in response to low-dose endotoxin Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1621 - H1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yang, J. Wu, C. M. Martin, P. R. Kvietys, and T. Rui Important role of p38 MAP kinase/NF-{kappa}B signaling pathway in the sepsis-induced conversion of cardiac myocytes to a proinflammatory phenotype Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H994 - H1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, J.-Y. Zhou, and G. S. Wu ERK-Dependent MKP-1 Mediated Cisplatin Resistance in Human Ovarian Cancer Cells Cancer Res., December 15, 2007; 67(24): 11933 - 11941. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Horsch, H. de Wet, M. M. Schuurmans, F. Allie-Reid, A. C. B. Cato, J. Cunningham, J. M. Burrin, F. S. Hough, and P. A. Hulley Mitogen-Activated Protein Kinase Phosphatase 1/Dual Specificity Phosphatase 1 Mediates Glucocorticoid Inhibition of Osteoblast Proliferation Mol. Endocrinol., December 1, 2007; 21(12): 2929 - 2940. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Newton and N. S. Holden Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor? Mol. Pharmacol., October 1, 2007; 72(4): 799 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.S. Patil and K.L. Kirkwood p38 MAPK Signaling in Oral-related Diseases J. Dent. Res., September 1, 2007; 86(9): 812 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Nelin, X. Wang, Q. Zhao, L. G. Chicoine, T. L. Young, D. M. Hatch, B. K. English, and Y. Liu MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge Am J Physiol Cell Physiol, August 1, 2007; 293(2): C632 - C640. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bhattacharyya, D. E. Brown, J. A. Brewer, S. K. Vogt, and L. J. Muglia Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase Blood, May 15, 2007; 109(10): 4313 - 4319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Doi, S. Cho, I. Yujnovsky, J. Hirayama, N. Cermakian, A. C. B. Cato, and P. Sassone-Corsi Light-Inducible and Clock-Controlled Expression of MAP Kinase Phosphatase 1 in Mouse Central Pacemaker Neurons J Biol Rhythms, April 1, 2007; 22(2): 127 - 139. [Abstract] [PDF] |
||||
![]() |
K. Salojin and T. Oravecz Regulation of innate immunity by MAPK dual-specificity phosphatases: knockout models reveal new tricks of old genes J. Leukoc. Biol., April 1, 2007; 81(4): 860 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, H. Yang, S. D. Tachado, J. E. Capo-Aponte, V. N. Bildin, H. Koziel, and P. S. Reinach Phosphatase-Mediated Crosstalk Control of ERK and p38 MAPK Signaling in Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5267 - 5275. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lang, M. Hammer, and J. Mages DUSP Meet Immunology: Dual Specificity MAPK Phosphatases in Control of the Inflammatory Response J. Immunol., December 1, 2006; 177(11): 7497 - 7504. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Dickinson and S. M. Keyse Diverse physiological functions for dual-specificity MAP kinase phosphatases J. Cell Sci., November 15, 2006; 119(22): 4607 - 4615. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Schmidt, V. T. Thieu, B. A. Mann, A.-N. N. Ahyi, and M. H. Kaplan Bruton's Tyrosine Kinase Is Required for TLR-Induced IL-10 Production J. Immunol., November 15, 2006; 177(10): 7203 - 7210. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, J. Xu, J.-Y. Zhou, Y. Liu, and G. S. Wu Mitogen-Activated Protein Kinase Phosphatase-1 Is Required for Cisplatin Resistance. Cancer Res., September 1, 2006; 66(17): 8870 - 8877. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Abraham, T. Lawrence, A. Kleiman, P. Warden, M. Medghalchi, J. Tuckermann, J. Saklatvala, and A. R. Clark Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 J. Exp. Med., August 7, 2006; 203(8): 1883 - 1889. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sanchez-Tillo, M. Comalada, C. Farrera, A. F. Valledor, J. Lloberas, and A. Celada Macrophage-Colony-Stimulating Factor-Induced Proliferation and Lipopolysaccharide-Dependent Activation of Macrophages Requires Raf-1 Phosphorylation to Induce Mitogen Kinase Phosphatase-1 Expression. J. Immunol., June 1, 2006; 176(11): 6594 - 6602. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Zhou, Y. Liu, and G. S. Wu The Role of Mitogen-Activated Protein Kinase Phosphatase-1 in Oxidative Damage-Induced Cell Death. Cancer Res., May 1, 2006; 66(9): 4888 - 4894. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wen, J. Gu, S.-L. Li, M. A. Reddy, R. Natarajan, and J. L. Nadler Elevated Glucose and Diabetes Promote Interleukin-12 Cytokine Gene Expression in Mouse Macrophages Endocrinology, May 1, 2006; 147(5): 2518 - 2525. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, M. G. Schwacha, I. H. Chaudry, and M. A. Choudhry A role of PP1/PP2A in mesenteric lymph node T cell suppression in a two-hit rodent model of alcohol intoxication and injury J. Leukoc. Biol., March 1, 2006; 79(3): 453 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chi, S. P. Barry, R. J. Roth, J. J. Wu, E. A. Jones, A. M. Bennett, and R. A. Flavell Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses PNAS, February 14, 2006; 103(7): 2274 - 2279. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Salojin, I. B. Owusu, K. A. Millerchip, M. Potter, K. A. Platt, and T. Oravecz Essential Role of MAPK Phosphatase-1 in the Negative Control of Innate Immune Responses J. Immunol., February 1, 2006; 176(3): 1899 - 1907. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hammer, J. Mages, H. Dietrich, A. Servatius, N. Howells, A. C.B. Cato, and R. Lang Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock J. Exp. Med., January 23, 2006; 203(1): 15 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhao, X. Wang, L. D. Nelin, Y. Yao, R. Matta, M. E. Manson, R. S. Baliga, X. Meng, C. V. Smith, J. A. Bauer, et al. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock J. Exp. Med., January 23, 2006; 203(1): 131 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Tachado, J. Zhang, J. Zhu, N. Patel, and H. Koziel HIV Impairs TNF-{alpha} Release in Response to Toll-Like Receptor 4 Stimulation in Human Macrophages In Vitro Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 610 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Wu and A. M. Bennett Essential Role for Mitogen-activated Protein (MAP) Kinase Phosphatase-1 in Stress-responsive MAP Kinase and Cell Survival Signaling J. Biol. Chem., April 22, 2005; 280(16): 16461 - 16466. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |